Axsome Therapeutics (AXSM) Tax Provisions (2017 - 2025)

Axsome Therapeutics has disclosed Tax Provisions across 5 years of filings, most recently posting $460000.0 for Q4 2025.

• Tax Provisions for Q4 2025 came in at $460000.0, up 441.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$540000.0 (down 735.29% YoY), and the FY2025 annual result was -$500000.0, down 688.24% from the prior year.
• Tax Provisions came in at $460000.0 for Q4 2025 at Axsome Therapeutics, up from -$1.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $2.6 million in Q1 2023 to a low of -$1.0 million in Q2 2025.
• The 3-year median for Tax Provisions is -$325000.0 (2023), against an average of $77428.6.
• Across the five-year window, Tax Provisions surged 126.15% in 2024 and surged 441.18% in 2025, its largest moves.
• Axsome Therapeutics' Tax Provisions stood at -$325000.0 in 2023, then soared by 126.15% to $85000.0 in 2024, then soared by 441.18% to $460000.0 in 2025.
• The last three Tax Provisions figures came in at $460000.0 (Q4 2025), -$1.0 million (Q2 2025), and $85000.0 (Q4 2024), per Business Quant data.